<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    CTI BioPharma Corp.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About CTI BioPharma Corp.

    CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. In particular, we are focused on evaluating pacritinib for the treatment of adult patients with myelofibrosis. CTI BioPharma is headquartered in Seattle, Washington. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $120,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Adam R. Craig, M.D., Ph.D.
    • FOUNDED
      1991
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Athersys, Inc.

    Athersys, Inc.

    We are an international biotechnology company that is focused in the field of rege...

    We are an international biotechnology company t...

    Filing Type:    PU
    Sientra, Inc.

    Sientra, Inc.

    Headquartered in Santa Barbara, California, Sientra is a diversified global medica...

    Headquartered in Santa Barbara, California, Sie...

    Filing Type:    PU
    Verrica Pharmaceuticals Inc.

    Verrica Pharmaceuticals Inc.

    Verrica Pharmaceuticals Inc. is an innovative clinical-stage medical dermatology c...

    Verrica Pharmaceuticals Inc. is an innovative c...

    Filing Type:    PU
    Jaguar Health, Inc.

    Jaguar Health, Inc.

    Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on devel...

    Jaguar Health, Inc. is a commercial stage pharm...

    Filing Type:    PU
    Tiziana Life Sciences plc

    Tiziana Life Sciences plc

    Tiziana Life Sciences is a dual-listed (NASDAQ:TLSA, AIM:TILS) clinical stage biot...

    Tiziana Life Sciences is a dual-listed (NASDAQ:...

    Filing Type:    PU
    Sesen Bio, Inc.

    Sesen Bio, Inc.

    At Sesen Bio, we are committed to renewing life for people with cancer. We are a l...

    At Sesen Bio, we are committed to renewing life...

    Filing Type:    PU
    Aethlon Medical, Inc.

    Aethlon Medical, Inc.

    At Aethlon Medical, we are a leading developer of immunotherapeutic technologies t...

    At Aethlon Medical, we are a leading developer ...

    Filing Type:    PU
    Verastem, Inc.

    Verastem, Inc.

    Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committ...

    Verastem Oncology (Nasdaq: VSTM) is a commercia...

    Filing Type:    PU
    Regeneron Pharmaceuticals, Inc.

    Regeneron Pharmaceuticals, Inc.

    We are a leading science and technology company that delivers life-transforming me...

    We are a leading science and technology company...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.